North America Preservative-Free Eye Drops Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The North America Preservative-Free Eye Drops Market size is expected to reach US$ 741.5 Million by 2031 from US$ 532.7 Million in 2024. The market is estimated to record a CAGR of 4.9% from 2025 to 2031.

Executive Summary and North America Preservative-Free Eye Drops Market Analysis:

In North America, where OTC and prescription channels are well developed, the adoption of preservative-free eye drops is rapid. Growth is moderated by insurance coverage issues. The USFDA and Canadian regulatory authorities have been approving numerous preservative-free eye formulations, both as over-the-counter lubricants and in prescription ophthalmic drugs, for the last decade. Furthermore, innovation in packaging is evident, including multidose bottles and single-use vials, to make such products more convenient and safe. The launch of Prostaglandin Drop IYUZEH in 2023 for patients with glaucoma and LUMIFY PF in 2024 as a redness reliever has improved the awareness and demand for the long-term benefits associated with preservative-free eye drops in the region. A higher level of patient satisfaction, combined with the rising prevalence of glaucoma and dry eye disease, is expected to boost market growth.

North America Preservative-Free Eye Drops Market: Strategic Insights

North America Preservative-Free Eye Drops Market Segmentation Analysis:

• By Type, the North America Preservative-Free Eye Drops Market is segmented into Single-dose and Multiple-dose. Single-dose held the largest share of the market in 2024.
• By Application, the North America Preservative-Free Eye Drops Market is segmented into Dry Eye Disease (DED), Eye Allergy or Infection, Glaucoma, Retinal Disorder, and Other Indications. Dry Eye Disease (DED) held the largest share of the market in 2024.
• By Distribution Channel, the North America Preservative-Free Eye Drops Market is segmented into Hospital Pharmacies, Drug Stores, Retail Pharmacies, and Online Pharmacies. Hospital Pharmacies held the largest share of the market in 2024.

North America Preservative-Free Eye Drops Market Players Density: Understanding Its Impact on Business Dynamics

The North America Preservative-Free Eye Drops Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

North America Preservative-Free Eye Drops Market Outlook

There has been a noticeable increase in the global prevalence of eye disorders such as allergic conjunctivitis, dry eye disease, glaucoma, and related ophthalmic disorders, which are attributable to the increased screen time, rising proportion of aging populations, and environmental pollution. According to Lippincott Journal, around 1520% of the world population is estimated to suffer from ocular allergy in next few years. Furthermore, PubMed states that an estimated 4.22 million adults in the US had glaucoma in 2022 and about 1.49 million had vision affecting glaucoma. Thus, there is a growing demand for safer treatment options, including preservative-free eye drops.

Traditional eye drops often include benzalkonium chloride as preservative that exacerbate irritation on the ocular surface when used repeatedly. As patients suffering from conjunctivitis and dry eye disease require frequent application of eye drops over longer periods, clinicians are preferring to prescribing preservativefree options that are considered to be relatively gentler on the eye for long-term use. Preservative-free eye drops significantly reduce the risk of toxic side-effects to the eye and patients with sensitive ocular surfaces can use these drops with less risk of additional inflammation.

Both patients and clinicians have become increasingly aware of issues like ocular surface damage, preservative toxicity, and are thus building preferences for preservative-free formulations, which are expected to propel the growth of preservative-free eye drops market in near future.

North America Preservative-Free Eye Drops Market Country Insights

By country, the North America Preservative-Free Eye Drops Market is segmented into the United States, Canada and Mexico. The United States held the largest share in 2024.

The US is one of the largest markets for preservative-free eye drops, attributable to the aging population, high rate of digital screen use, and relatively high awareness of side-effects associated with the use of preservatives. Preservative-free artificial tears hold a large share of US artificial tears market revenue owing to rising prevalence of dry-eye disease in the country among all age groups. The USFDA has increasingly emphasized safety, sterility, and adverse effects of preservatives owing to which draft guidances and quality expectations in the US make preservative-free eye formulations more desirable. Hospitals and clinics in the US often prefer preservative-free options for patients with chronic disease. Furthermore, major players, including Bausch and Lomb, Alcon, etc., are actively engaged in introducing efficient preservative-free eye drops in the US, raising awareness of preservative-free formulations in the country.

In February 2025, Alcon launched a multi-dose preservative-free SYSTANE PRO in the U.S. as an OTC dry eye drop using a triple action formula (hyaluronate + nanolipids + HPGuar. New packaging technologies, such as PureFlow, oneway valves, advanced nozzles, are enabling preservative-free multidose formulations with better sterility and cost control, which is propelling the demand for preservative-free formulations in the US.

North America Preservative-Free Eye Drops Market Company Profiles

Some of the key players operating in the market include Bayer AG, Santen Pharmaceutical Co., Ltd., AbbVie Inc, Sun Pharmaceutical Industries Ltd, Prestige Consumer Healthcare Inc., Alcon AG, Bausch + Lomb Corporation, Nemera, Laboratoires Thea, Kiltch Healthcare

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Preservative-Free Eye Drops Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise